Association of Positional Candidate Gene Variants with SLE

位置候选基因变异与 SLE 的关联

基本信息

  • 批准号:
    8126251
  • 负责人:
  • 金额:
    $ 50.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-09-30 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our goal is to identify major genetic risk factors for the development of systemic lupus erythematosus (SLE) that are common to multiple ethnic groups. During the last decade, more than 10 whole genome linkage scans have mapped many SLE susceptibility loci. Evidence for linkage to SLE at 1q23-25 and 1q31-32 have been identified and confirmed by our group and other investigators using multiplex families of Caucasian, African- American, Mexican-American, or other ethnic origins. We hypothesize that 1q contains SLE susceptibility genes shared by more than one ethnic group. To this end, we have evidence for association of SLE susceptibility with four positional candidate genes (PBX1 and OX40L in 1q23-25, and CFH/CFHR3/CFHR1 and CR2 in 1q31-32) in two or more ethnic groups, including association of copy number variants (CNVs) of CFH/CFHR3/CFHR1 with SLE. An anonymous 1q25.1 locus has recently been identified as one of the 4 novel associations with SLE in whole genome association (WGA) and replication studies of Caucasian cases and controls conducted by the SLE Genetic consortium (SLEGEN) using 317,000 SNPs. Because of the high cost of WGA for replicating in independent Caucasian samples and for extending WGA to each of the non- Caucasian ethnic groups, we propose to conduct a targeted genome association study using both high-density SNPs and CNVs covering the two 1q intervals (1q23-25 plus 1q31-32) that have strong linkage and association evidence in multiple ethnic groups. In addition, we plan to assess novel genes identified in WGA studies in SLE and other autoimmune diseases for association with SLE in our independent samples. Samples available for this study are from > 15,000 subjects including Caucasian, Asian, and African-American cohorts. We anticipate that these experiments will identify major genetic effects located in chromosome 1q as well as novel gene variants associated with SLE that are common to several ethnic groups. Results of these association studies will lead to localization of causal gene variants (SNPs and/or CNVs), and characterization of their effects on the gene products. Knowledge gained from these studies may reveal new paradigms for the pathogenesis of the disease, and may provide new therapeutic targets for disease management. Common risk variants to several, but not all, autoimmune diseases will help elucidate both shared and unique pathways underlying these complex disorders. 7. PUBLIC HEALTH RELEVANCE This study aims to identify major genetic risk factors, located on the long arm of chromosome 1, that increase risk for systemic lupus erythematosus (SLE). If we identify a particular genetic factor that is shared by more than one ethnic group, it is likely to play an important role in the pathogenesis of lupus. The identification of novel genes common to multiple ethnic groups will yield new insights into the mechanisms underlying the disease, which may lead to the development of specific targets for therapeutic interventions.
描述(由申请人提供):我们的目标是确定系统性红斑狼疮(SLE)发展的主要遗传危险因素,这些因素在多个种族中很常见。在过去的十年中,超过10个全基因组连锁扫描已经定位了许多SLE易感基因座。我们的研究小组和其他研究人员使用高加索人、非洲裔美国人、墨西哥裔美国人或其他种族的多重家族鉴定并证实了1 q23 -25和1 q31 -32与SLE相关的证据。我们假设1 q包含SLE易感基因共享一个以上的种族。为此,我们有证据表明SLE易感性与两个或多个种族中的四个位置候选基因(1 q23 -25中的PBX 1和OX 40 L,以及1 q31 -32中的CFH/CFHR 3/CFHR 1和CR 2)相关,包括CFH/CFHR 3/CFHR 1的拷贝数变异(CNV)与SLE相关。最近,在SLE遗传学联盟(SLEGEN)使用317,000个SNP对高加索病例和对照进行的全基因组关联(WGA)和复制研究中,一个匿名的1q25.1位点被确定为与SLE的4个新关联之一。由于WGA在独立高加索样本中复制以及将WGA扩展到每个非高加索种族的成本很高,我们建议使用覆盖两个1 q间隔的高密度SNP和CNV进行靶向基因组关联研究(1 q23 -25加1 q31 -32),这些间隔在多个种族中具有强有力的连锁和关联证据。此外,我们计划在我们的独立样本中评估在SLE和其他自身免疫性疾病的WGA研究中发现的与SLE相关的新基因。可用于本研究的样品来自> 15,000名受试者,包括高加索人、亚洲人和非洲裔美国人队列。我们预计,这些实验将确定主要的遗传效应位于染色体1 q以及新的基因变异与SLE是常见的几个种族群体。这些关联研究的结果将导致致病基因变异(SNP和/或CNV)的定位,并表征其对基因产物的影响。从这些研究中获得的知识可能揭示疾病发病机制的新范式,并可能为疾病管理提供新的治疗靶点。几种但不是所有自身免疫性疾病的常见风险变体将有助于阐明这些复杂疾病的共同和独特途径。7.公共卫生相关性本研究旨在确定位于1号染色体长臂上的主要遗传风险因素,这些因素会增加系统性红斑狼疮(SLE)的风险。如果我们确定一个特定的遗传因素是由一个以上的种族群体共享,它很可能在狼疮的发病机制中发挥重要作用。鉴定多个种族群体共有的新基因将对疾病的潜在机制产生新的见解,这可能导致开发治疗干预的特定靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BETTY P TSAO其他文献

BETTY P TSAO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BETTY P TSAO', 18)}}的其他基金

The role of human SLE causal variant NCF1.pR90H in promoting kidney damage
人类SLE致病变异N​​CF1.pR90H在促进肾脏损伤中的作用
  • 批准号:
    10740630
  • 财政年份:
    2023
  • 资助金额:
    $ 50.21万
  • 项目类别:
Pathogenic role of SAT1 variants in monogenic lupus
SAT1 变异在单基因狼疮中的致病作用
  • 批准号:
    9920091
  • 财政年份:
    2019
  • 资助金额:
    $ 50.21万
  • 项目类别:
Association of Androgen Receptor Polymorphisms with Damage in SLE
雄激素受体多态性与 SLE 损伤的关联
  • 批准号:
    9267190
  • 财政年份:
    2016
  • 资助金额:
    $ 50.21万
  • 项目类别:
Association of Androgen Receptor Polymorphisms with Damage in SLE
雄激素受体多态性与 SLE 损伤的关联
  • 批准号:
    8619113
  • 财政年份:
    2013
  • 资助金额:
    $ 50.21万
  • 项目类别:
Association of Androgen Receptor Polymorphisms with Damage in SLE
雄激素受体多态性与 SLE 损伤的关联
  • 批准号:
    8738406
  • 财政年份:
    2013
  • 资助金额:
    $ 50.21万
  • 项目类别:
Fine Mapping and Functional Analysis of RANKL Variants in Early RA Onset
RA 早期 RANKL 变异的精细定位和功能分析
  • 批准号:
    7477907
  • 财政年份:
    2007
  • 资助金额:
    $ 50.21万
  • 项目类别:
Fine Mapping and Functional Analysis of RANKL Variants in Early RA Onset
RA 早期发病时 RANKL 变异的精细定位和功能分析
  • 批准号:
    7295106
  • 财政年份:
    2007
  • 资助金额:
    $ 50.21万
  • 项目类别:
THE ROLE OF THE PARP GENE IN SLE SUSCEPTIBILITY
PARP 基因在 SLE 易感性中的作用
  • 批准号:
    2902183
  • 财政年份:
    1999
  • 资助金额:
    $ 50.21万
  • 项目类别:
MAP THE SUSCEPTIBILITY GENE IN CHINESE SLE SIBPAIRS
绘制中国 SLE SIBP 对的易感基因图谱
  • 批准号:
    6188692
  • 财政年份:
    1998
  • 资助金额:
    $ 50.21万
  • 项目类别:
MAP THE SUSCEPTIBILITY GENE IN CHINESE SLE SIBPAIRS
绘制中国 SLE SIBP 对的易感基因图谱
  • 批准号:
    6078400
  • 财政年份:
    1998
  • 资助金额:
    $ 50.21万
  • 项目类别:

相似海外基金

Systemic complement and age-related macular degeneration.
全身补体和年龄相关性黄斑变性。
  • 批准号:
    8913193
  • 财政年份:
    2014
  • 资助金额:
    $ 50.21万
  • 项目类别:
Celiac Disease: Identifying Causal Variants from GWAS
乳糜泻:通过 GWAS 识别致病变异
  • 批准号:
    8086167
  • 财政年份:
    2010
  • 资助金额:
    $ 50.21万
  • 项目类别:
Functional analysis of AMD-associated HTRA1 promoter polymorphism
AMD相关HTRA1启动子多态性的功能分析
  • 批准号:
    7915555
  • 财政年份:
    2009
  • 资助金额:
    $ 50.21万
  • 项目类别:
Functional analysis of AMD-associated HTRA1 promoter polymorphism
AMD相关HTRA1启动子多态性的功能分析
  • 批准号:
    7639793
  • 财政年份:
    2009
  • 资助金额:
    $ 50.21万
  • 项目类别:
Whole Genome Association Study of Migraine in Women
女性偏头痛的全基因组关联研究
  • 批准号:
    7693740
  • 财政年份:
    2008
  • 资助金额:
    $ 50.21万
  • 项目类别:
Whole Genome Association Study of Migraine in Women
女性偏头痛的全基因组关联研究
  • 批准号:
    7940906
  • 财政年份:
    2008
  • 资助金额:
    $ 50.21万
  • 项目类别:
Whole Genome Association Study of Migraine in Women
女性偏头痛的全基因组关联研究
  • 批准号:
    7580187
  • 财政年份:
    2008
  • 资助金额:
    $ 50.21万
  • 项目类别:
Core C
核心C
  • 批准号:
    7436121
  • 财政年份:
    2007
  • 资助金额:
    $ 50.21万
  • 项目类别:
Genomic Instability and Evolution of Drug Resistance
基因组不稳定性和耐药性的演变
  • 批准号:
    7201643
  • 财政年份:
    2004
  • 资助金额:
    $ 50.21万
  • 项目类别:
Genomic Instability and Evolution of Drug Resistance
基因组不稳定性和耐药性的演变
  • 批准号:
    7380083
  • 财政年份:
    2004
  • 资助金额:
    $ 50.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了